Skip to search formSkip to main contentSkip to account menu

glucagon-like peptide-1(28-36)amide

Known as: phenylalanyl-isoleucyl-alanyl-tryptophyl-leucyl-valyl-lysyl-glycyl-argininamide, GLP1(28-36)amide, GLP-1(28-36)amide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Glucagon-Like Peptide 1Peptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
GLP-1(28-36)amide, a Long Ignored Peptide Revisited
Glucagon-like peptide-1 (GLP-1), which has been extensively applied for treating type 2 diabetes mellitus (T2DM), is an incretin… 
2002
2002
Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models.
1998
1998
Inositolphosphoglycans possibly mediate the effects of glucagon‐like peptide‐1(7‐36)amide on rat liver and adipose tissue
Insulin‐like effects of glucagon‐like peptide‐1(7‐36)amide (GLP‐1) in rat liver, skeletal muscle and fat, and also the presence… 
1998
1998
Effects of glucagon-like peptide-1 (7-36)amide on insulin stimulated rat skeletal muscle glucose transport
Abstract Glucagon-like peptide-1 binding sites have been reported in peripheral tissues including muscle. However, the potential… 
Highly Cited
1997
Highly Cited
1997
Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.
The GLP-1 structurally related peptides exendin-4 and exendin(9-39)amide were found to act, in rat liver and skeletal muscle, as… 
1997
1997
Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay
1996
1996
Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7–36)amide action in the liver
A potent glycogenic effect for GLP-1 (7–36)amide has been found in rat hepatocytes and skeletal muscle, and the specific… 
1993
1993
Effects of glucagon like peptide-1(7-36) amide on the cytoplasmic Ca(2+)-concentration in rat islet cells.
Glucagon like peptide-1(7-36) amide (GLP-1(7-36)amide) stimulates both insulin secretion and the efflux of 45Ca2+ from 45Ca(2… 
1990
1990
Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells.
Glucagon-like peptide-1(7-36)amide (GLP-1(7-36)amide) is a potent stimulator of insulin secretion. Receptors for this hormone… 
1990
1990
Dexamethasone pretreatment of rat insulinoma cells decreases binding of glucagon-like peptide-1(7-36)amide.
The effect of dexamethasone on binding of glucagon-like peptide-1(7-36)amide (GLP-1(7-36)amide) to rat insulinoma-derived cells… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)